• Research

    Value, Momentum, and the Outlook for Market Neutral L/S

    Momentum stocks experienced a correction since Pfizer announced their Covid-19 vaccine results early November.

  • Press releases

    Societe Generale Entry into exclusive negotiation with Amundi with a view to disposing of the asset management activities of Lyxor

    Societe Generale announced it has entered into exclusive negotiations with a view to sell the asset management businesses operated by Lyxor Asset Management to Amundi. This project has been submitted to the relevant labour representatives in France and in Europe.

  • Research

    Bullish Outlook for European Event-Driven Strategies

    After a pause early last year due to the pandemic, corporate operations are accelerating in Europe by most measures. The number of M&A and asset sales is soaring, and each month sees a new lot of IPOs, spinoffs, or SPACs. Signs of greater “animal spirit” are evidenced by rising venture capital flows, more unsolicited acquisitions and leveraged buyouts.

  • Research

    Alternative Outlook: Stay Overweight Event-Driven & CTAs

    Alternative strategies saw exciting developments in Q1, in a context where equities and bonds experienced opposite fates. We estimate alternative strategies were up +1.2% quarter-to-date (as of March 19th), while the MSCI World was up 5% and the Barclays Global Aggregate was down -2.6%.

  • Expert Opinions

    Seeking Reward for the Right Risks

    Government and central bank responses to the Covid19 pandemic may have calmed equity and bond markets, but they have not removed long-standing structural risks.

  • Expert Opinions

    Should investors be afraid of a return of inflation?

    How should investors protect their portfolios against inflation? Lyxor Senior Cross-Asset Strategist Philippe Ferreira gives his views on the situation.